Officers
President
J. Chris (Jack) Bradberry, PharmD, FNLA
Omaha, NE
Financial Disclosures
President Elect
Tara Lynn Dall, MD, FNLA
Delafield, WI
Financial Disclosures
Treasurer
Alan S. Brown, MD, FACC, FNLA
Naperville, IL
Financial Disclosures
Secretary
Janet L. Maxson, PhD, APN-PC, FNLA
Minot, ND
Financial Disclosures
Immediate Past-President
Carl E. Orringer, MD, FNLA
Cleveland, OH
Financial Disclosures
Board Members
Term Expiring 2012
Brian Scott Edwards, MD, FNLA
Topeka, KS
Financial Disclosures
David Harold Hoisington, MD, FNLA
Lansing, MI
Financial Disclosures
Theodore Mazzone, MD, FNLA
Evanston, IL
Financial Disclosures
Scott Webster Shurmur, MD, FNLA
Omaha, NE
Financial Disclosures
Gail L. Underbakke, RD, MS, FNLA
Madison, WI
Financial Disclosures
Term Expiring 2013
Stephen R. Crespin, MD, FNLA
Saint Louis, MO
Financial Disclosures
Scott H. Merryman, MD
Columbus, OH
Financial Disclosures
Katherine S. Rhodes, PhD, RD
Ann Arbor, MI
Financial Disclosures
Tonimarie Swartz, PharmD
Timberlake, OH
Financial Disclosures
Peter P. Toth, MD, PhD, FAAFP, FAHA, FN
Sterling, IL
Financial Disclosures
Term Expiring 2014
Becky K. Captain, MSN
Kansas City, MO
Financial Disclosures
Edgar V. Lerma, MD, FNLA
Berwyn, IL
Financial Disclosures
Kevin Carl Maki, PhD, FNLA
Glen Ellyn, IL
Financial Disclosures
Suneet Verma, MD
Cherry Hill, NJ
Financial Disclosures
Kaye-Eileen Willard, MD
Racine, WI
Financial Disclosures
Executive Director
Christopher Seymour, MBA
(Disclosure not applicable)
|
J. Chris (Jack) Bradberry, PharmD, FNLA
Spring 2013 Clinical Lipid Update
February 22-24, 2013
Hosted by MWLA and SWLA
The Roosevelt Hotel
New Orleans, LA
Message from the President of the Midwest Lipid Association:
Welcome to the MWLA website. It is my distinct pleasure to serve as your President for 2011-2012.
This past year was an outstanding success led by immediate past-President Dr. Carl Orringer. Under Carl's
guidance a number of successful programs were developed and implemented, including an outstanding webinar
on the Jupiter trial with Dr. Paul Ridker. Our incoming officers this year, Dr. Tara Dall, President-elect;
Dr. Alan Brown, Treasurer; Dr. Janet Maxson, Secretary; and Immediate Past-President Dr. Carl Orringer, comprise
the Executive Committee of the MWLA Board of Directors. We have an outstanding leadership team in place to
serve our members along with superb NLA staff support.
Our focuses this year will be two-fold: maintaining excellence in our member programming and enhancing our
membership. One of the unique advantages of our organization is that we are both multidisciplinary and
interdisciplinary and the character of our membership certainly reflects this uniqueness. The world of
clinical lipidology has changed dramatically since the NLA came on the scene. Since the NLA and our regional
associations had the good fortune to have visionary leadership and motivated members from the very beginning,
our specialty has become recognized nationally and internationally, and is the source of significant influence
in the clinical care of patients with dyslipidemias. Of course, membership support is vital to bring clinical
lipidology to the next level.
Our MWLA Chapter is very active and our membership profile compared to NLA is below:
MWLA membership = 624
NLA membership = 2825
MWLA ABCL certifications = 125
MWLA CLS certifications = 28
Clearly, two of our MWLA membership goals should be to increase overall membership and the number of board
certified members. NLA at the national level has membership marketing and allied health membership enhancement
as two strategic goals for growth. These goals are important for us in MWLA to also embrace, as we strive to
enhance our member ranks. Think about how each one of us can assist in these goals. Membership is very dependent
upon local efforts, so I encourage each of our MWLA members to reach out to potential members in our local
communities. We have a great story to share and NLA has fabulous resources to help support members. So, let's
continue to tell our story and thusly enhance our membership!
Please feel free to contact any of the Executive Committee members by email if we can assist you in any way.
Best wishes to all for this next year and I look forward to seeing you at one of our future meetings.
Sincerely,
J. Chris Bradberry, PharmD, FAHA, FNLA
Diplomate of the Accreditation Council for Clinical Lipidology
Serving the States of: Indiana, Illinois, Wisconsin, Michigan, Ohio, Kansas, Iowa, Missouri, North Dakota, South Dakota, Minnesota, Nebraska
|
